<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02543125</url>
  </required_header>
  <id_info>
    <org_study_id>guangdongwchhi4</org_study_id>
    <nct_id>NCT02543125</nct_id>
  </id_info>
  <brief_title>Nasal High Frequency Oscillatory Versus Nasal Intermittent Positive Pressure Ventilation in Neonate After Extubation</brief_title>
  <official_title>Nasal High Frequency Oscillatory Versus Nasal Intermittent Positive Pressure Ventilation in Neonate After Extubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gao WeiWei</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangdong Women and Children Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy and safety of nasal high frequency oscillatory ventilation(NHFOV) in
      preterms with respiratory disease syndrome(RDS) after extubation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To very low birth weight infant(VLBW) with respiratory disease syndrome(RDS) who need
      mechanical ventilation,early extubation may have more benefits.Early extubation may decrease
      the ventilation-associated pneumonia(VAP),sepsis and decrease the incidence of severity
      bronchopulmonary dysplasia(BPD).But often fail attempts at extubation because of
      apnea,atelectasis,hypercapnia,hypoventilation or other illnesses.

      High frequency oscillatory ventilation is benefit to lung.Initial ventilation with HFOV in
      preterm with RDS may reduce the incidence of BPD and improve the neurodevelopment.Compared
      HFOV with conventional ventilation in preterm infants showed that HFOV had superior lung
      function when 11 to 14 years age.Whether nasal high frequency oscillatory ventilation(NHFOV)
      also have those advantages in non-invasive mode? Null D M et al do a experiment on preterm
      lambs,the result suggest that NHFOV may promotes alveolarization.But there was no clinical
      trials to prove.

      The nasal intermittent positive pressure ventilation (NIPPV) group fail definition：1、
      Fraction of inspired oxygen (FiO2)&gt;40%、MAP&gt;12 centimeter water column (cm H2O),but arterial
      oxygen saturation (SaO2)&lt;90%.2、significant abdominal distension.3、PaCO2&gt;60millimeter of
      mercury(mmHg)or partial pressure of arterial oxygen (PaO2)&lt;45 millimeter of
      mercury(mmHg).4、severe apnea( definition:&gt;6 episodes requiring stimulation in 6 hours or
      requiring &gt;1 episodes of positive-pressure ventilation) 5.potential of hydrogen (PH)&lt;7.2 The

      The NHFOV group fail definition：1、FiO2&gt;40%、MAP&gt;14 mbar,but SaO2&lt;90%.2、significant abdominal
      distension.3、PaCO2&gt;60millimeter of mercury(mmHg) or PaO2&lt;45millimeter of
      mercury(mmHg).4、severe apnea 5.PH&lt;7.2.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intubation rate</measure>
    <time_frame>72 hours</time_frame>
    <description>endotracheal intubation rate assessed within 72 hours after extubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>significant apnea</measure>
    <time_frame>7 days</time_frame>
    <description>significant apnea measured by Colin J definition:6 episodes requiring stimulation in 6 hours or requiring &gt; 1episodes of positive ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>air leaks</measure>
    <time_frame>3 months</time_frame>
    <description>air leaks assessed by chest X-ray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bronchopulmonary dysplasia</measure>
    <time_frame>3 months</time_frame>
    <description>Bronchopulmonary dysplasia assessed by national institute of child health and human development definition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>necrotizing enterocolitis</measure>
    <time_frame>3 months</time_frame>
    <description>necrotizing enterocolitis assessed by abdominal X-ray and Bell classification</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>NIPPV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NIPPV is provided via binasal prongs. Ventilator settings:FiO2:21-40%,peak inspiratory pressure( PIP)：12-22cm H2O,positive and expiratory pressure(PEEP):5-7cm H2O,Rate:30-60 per minute to maintain SaO2 at 90-95%,The weaning process is left to the discretion of the attending physician,when FiO2: 25%,mean airway pressure (MAP)&lt;6cm H2O,R:30 per minute .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NHFOV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NHFOV is provided via binasal prongs. Ventilator settings:FiO2:21-40%,MAP：6-14 cm H2O,Hertz(HZ):5-10 to maintain SaO2 at 90-95%,The weaning process is left to the discretion of the attending physician,when FiO2: 25%,mean airway pressure (MAP)&lt;6cm H2O.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NIPPV</intervention_name>
    <description>For infants in the NIPPV-group who &quot;fail&quot;NIPPV (see definition below), need immediate intubation, a invasive &quot;Rescue-Treatment&quot; may be provided. The decision to attempt &quot;Rescue-Treatment&quot;, the mode of respiratory support and the ventilator settings used are at the discretion of the attending clinician.</description>
    <arm_group_label>NIPPV</arm_group_label>
    <other_name>SLE 5000</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NHFOV</intervention_name>
    <description>For infants in the NHFOV-group who &quot;fail&quot;NHFOV (see definition below), need immediate intubation, a invasive &quot;Rescue-Treatment&quot; may be provided. The decision to attempt &quot;Rescue-Treatment&quot;, the mode of respiratory support and the ventilator settings used are at the discretion of the attending clinician.</description>
    <arm_group_label>NHFOV</arm_group_label>
    <other_name>SLE 5000</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. birth weight&gt;1000g

          2. gestational age &gt;28 weeks

          3. have respiratory distress syndrome and need invasive ventilation

        Exclusion Criteria:

          1. birth wight&lt;1000g

          2. gestational age &lt;28 weeks

          3. infants wiht abnormalities of upper and lower airways

          4. infants have contraindications of non-invasive ventilation -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>yang jie, doctor</last_name>
    <role>Study Director</role>
    <affiliation>Guangdong Women and Children Hospital</affiliation>
  </overall_official>
  <results_reference>
    <citation>Donn SM, Sinha SK. Minimising ventilator induced lung injury in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2006 May;91(3):F226-30. Review.</citation>
    <PMID>16632652</PMID>
  </results_reference>
  <results_reference>
    <citation>van der Hoeven M, Brouwer E, Blanco CE. Nasal high frequency ventilation in neonates with moderate respiratory insufficiency. Arch Dis Child Fetal Neonatal Ed. 1998 Jul;79(1):F61-3.</citation>
    <PMID>9797628</PMID>
  </results_reference>
  <results_reference>
    <citation>Colaizy TT, Younis UM, Bell EF, Klein JM. Nasal high-frequency ventilation for premature infants. Acta Paediatr. 2008 Nov;97(11):1518-22. doi: 10.1111/j.1651-2227.2008.00900.x. Epub 2008 Jun 9.</citation>
    <PMID>18549418</PMID>
  </results_reference>
  <results_reference>
    <citation>De Luca D, Carnielli VP, Conti G, Piastra M. Noninvasive high frequency oscillatory ventilation through nasal prongs: bench evaluation of efficacy and mechanics. Intensive Care Med. 2010 Dec;36(12):2094-100. doi: 10.1007/s00134-010-2054-7. Epub 2010 Sep 21.</citation>
    <PMID>20857278</PMID>
  </results_reference>
  <results_reference>
    <citation>Null DM, Alvord J, Leavitt W, Wint A, Dahl MJ, Presson AP, Lane RH, DiGeronimo RJ, Yoder BA, Albertine KH. High-frequency nasal ventilation for 21 d maintains gas exchange with lower respiratory pressures and promotes alveolarization in preterm lambs. Pediatr Res. 2014 Apr;75(4):507-16. doi: 10.1038/pr.2013.254. Epub 2013 Dec 30.</citation>
    <PMID>24378898</PMID>
  </results_reference>
  <results_reference>
    <citation>Fischer HS, Bohlin K, Bührer C, Schmalisch G, Cremer M, Reiss I, Czernik C. Nasal high-frequency oscillation ventilation in neonates: a survey in five European countries. Eur J Pediatr. 2015 Apr;174(4):465-71. doi: 10.1007/s00431-014-2419-y. Epub 2014 Sep 18.</citation>
    <PMID>25227281</PMID>
  </results_reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2015</study_first_submitted>
  <study_first_submitted_qc>September 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2015</study_first_posted>
  <last_update_submitted>February 22, 2016</last_update_submitted>
  <last_update_submitted_qc>February 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Guangdong Women and Children Hospital</investigator_affiliation>
    <investigator_full_name>Gao WeiWei</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>very low birth weight</keyword>
  <keyword>respiratory distress</keyword>
  <keyword>NHFOV</keyword>
  <keyword>NIPPV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

